Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 121-130 of 151 for Amyloidosis

Edit search filters
  1. ConTTRibute: A Global Observational Study Of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis) (ConTTRibute)

    Jacksonville, FL

  2. Intracardiac Flow Assessment in Cardiac Amyloidosis

    Rochester, MN

  3. An Outcome Survey To Better Understand And Characterize The Natural History Of Transthyretin-Associated Amyloidoses By Studying A Large And Diverse Patient Population

    Rochester, MN

  4. A Study to Evaluate Collecting of Health Related Quality of Life Data in Newly Diagnosed AL Amyloidosis Patients

    Rochester, MN

  5. A Study Of MCG In Cardiac Amyloidosis

    Rochester, MN

  6. Blood-based Biomarkers for Early Disease Detection in Cardiac Amyloidosis

    Scottsdale/Phoenix, AZ

  7. Multi-Organ Magnetic Resonance Elastography to Monitor Treatment Response in Light Chain (AL) Amyloidosis

    Rochester, MN

  8. A Study to Collect Data and Blood Samples from Mayo Patients Who Have or are Suspected of Having Amyloidosis, or Their Family Members, for Future Research

    Rochester, MN

  9. A Study of Chemotherapy in Patients with Immunoglobulin Light (or Heavy) Chain Amyloidosis

    Rochester, MN

  10. A Study Of The Natural History Of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer